2025. The Predicting Effect of ASXL1 Mutation on BCR-ABL Transcript Types and Responses to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia. Medical Forum Monthly. 36, 8 (Sep. 2025). DOI:https://doi.org/10.60110/medforum.360805.